Why is Maitreya Medica. falling/rising?

As of 28-Oct, Maitreya Medicare Ltd's stock price is currently at 237.00, reflecting a decline of 11.5 points or 4.63%. The stock has underperformed its sector by 4.99% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 5.95%, and its year-to-date return stands at a significant drop of 29.50%. Additionally, the company's profits have fallen by 40% over the past year, contributing to a return of -35.20% in the last year. Despite having a low Debt to EBITDA ratio of 0.30, which indicates a strong ability to service debt, the overall poor performance in terms of operating profit growth and a negative PAT for the quarter have negatively impacted investor sentiment.
In the broader market context, Maitreya Medicare Ltd's recent performance contrasts sharply with the Sensex, which has gained 0.26% over the past week and 9.69% year-to-date. This underperformance highlights the company's struggles, as it has consistently lagged behind the benchmark indices over various time frames, including the last three years and one year. The stock's liquidity appears adequate for trading, but the declining delivery volume suggests waning investor interest, further exacerbating its downward trajectory. Overall, the combination of poor financial results, negative growth indicators, and underperformance relative to the market contributes to the stock's current decline.